Millennium Management’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.11M Buy
3,322,053
+1,480,746
+80% +$2.97M ﹤0.01% 2387
2025
Q4
$2.52M Sell
1,841,307
-1,548,719
-46% -$2.04M ﹤0.01% 3736
2025
Q3
$4.2M Buy
3,390,026
+1,887,302
+126% +$2.25M ﹤0.01% 3324
2025
Q2
$1.7M Buy
1,502,724
+1,245,875
+485% +$1.66M ﹤0.01% 4019
2025
Q1
$375K Buy
+256,849
New +$484K ﹤0.01% 4980
2024
Q4
Sell
-258,002
Closed -$722K 5914
2024
Q3
$722K Buy
258,002
+78,378
+44% +$209K ﹤0.01% 4535
2024
Q2
$419K Sell
179,624
-21,846
-11% -$64.4K ﹤0.01% 4710
2024
Q1
$901K Sell
201,470
-1,717,544
-90% -$7.17M ﹤0.01% 4383
2023
Q4
$6.16M Buy
1,919,014
+1,794,616
+1,443% +$5.09M ﹤0.01% 2613
2023
Q3
$394K Sell
124,398
-85,368
-41% -$374K ﹤0.01% 4785
2023
Q2
$1.04M Sell
209,766
-793,230
-79% -$4.29M ﹤0.01% 4010
2023
Q1
$4.96M Sell
1,002,996
-2,272,128
-69% -$14.6M ﹤0.01% 2609
2022
Q4
$20.6M Buy
3,275,124
+1,878,645
+135% +$17.4M 0.01% 1423
2022
Q3
$15.1M Buy
1,396,479
+619,607
+80% +$8.42M 0.01% 1640
2022
Q2
$8.86M Buy
776,872
+205,666
+36% +$1.83M 0.01% 2191
2022
Q1
$5.2M Buy
571,206
+416,173
+268% +$4.33M ﹤0.01% 2889
2021
Q4
$2.31M Sell
155,033
-73,590
-32% -$1.3M ﹤0.01% 3642
2021
Q3
$5.88M Sell
228,623
-276,672
-55% -$6.57M ﹤0.01% 2680
2021
Q2
$13.2M Buy
505,295
+222,330
+79% +$6.34M 0.01% 1591
2021
Q1
$9.99M Sell
282,965
-142,517
-33% -$4.81M 0.01% 1777
2020
Q4
$10.7M Buy
425,482
+357,234
+523% +$11.6M 0.01% 1651
2020
Q3
$2.57K Sell
68,248
-138,931
-67% -$5.24M ﹤0.01% 2403
2020
Q2
$8.87M Buy
207,179
+155,678
+302% +$5.63M 0.01% 1301
2020
Q1
$1M Sell
51,501
-20,392
-28% -$486K ﹤0.01% 2464
2019
Q4
$1.87M Buy
+71,893
New +$1.98M ﹤0.01% 2662

Other funds holding ALLO